Literature DB >> 33462517

Ebola virus glycoprotein interacts with cholesterol to enhance membrane fusion and cell entry.

Jinwoo Lee1,2,3, Alex J B Kreutzberger1,2, Laura Odongo1,2, Elizabeth A Nelson1,4, David A Nyenhuis1,5, Volker Kiessling1,2, Binyong Liang1,2, David S Cafiso1,5, Judith M White1,4, Lukas K Tamm6,7.   

Abstract

Cholesterol serves critical roles in enveloped virus fusion by modulating membrane properties. The glycoprotein (GP) of Ebola virus (EBOV) promotes fusion in the endosome, a process that requires the endosomal cholesterol transporter NPC1. However, the role of cholesterol in EBOV fusion is unclear. Here we show that cholesterol in GP-containing membranes enhances fusion and the membrane-proximal external region and transmembrane (MPER/TM) domain of GP interacts with cholesterol via several glycine residues in the GP2 TM domain, notably G660. Compared to wild-type (WT) counterparts, a G660L mutation caused a more open angle between MPER and TM domains in an MPER/TM construct, higher probability of stalling at hemifusion for GP2 proteoliposomes and lower cell entry of virus-like particles (VLPs). VLPs with depleted cholesterol show reduced cell entry, and VLPs produced under cholesterol-lowering statin conditions show less frequent entry than respective controls. We propose that cholesterol-TM interactions affect structural features of GP2, thereby facilitating fusion and cell entry.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33462517      PMCID: PMC7992113          DOI: 10.1038/s41594-020-00548-4

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  71 in total

1.  Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Authors:  T Maruyama; L L Rodriguez; P B Jahrling; A Sanchez; A S Khan; S T Nichol; C J Peters; P W Parren; D R Burton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Science under fire: Ebola researchers fight to test drugs and vaccines in a war zone.

Authors:  Amy Maxmen
Journal:  Nature       Date:  2019-08       Impact factor: 49.962

3.  Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies.

Authors:  H Ito; S Watanabe; A Takada; Y Kawaoka
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Post-Ebolavirus disease syndrome: what do we know?

Authors:  Francisco Javier Carod-Artal
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08-13       Impact factor: 5.091

5.  Post-Ebola syndrome.

Authors:  Talha Khan Burki
Journal:  Lancet Infect Dis       Date:  2016-07       Impact factor: 25.071

Review 6.  Ebola haemorrhagic fever.

Authors:  Heinz Feldmann; Thomas W Geisbert
Journal:  Lancet       Date:  2011-03-05       Impact factor: 79.321

Review 7.  Ebola virus: unravelling pathogenesis to combat a deadly disease.

Authors:  Thomas Hoenen; Allison Groseth; Darryl Falzarano; Heinz Feldmann
Journal:  Trends Mol Med       Date:  2006-04-17       Impact factor: 11.951

Review 8.  [Illness due the Ebola virus: epidemiology and clinical manifestations within the context of an international public health emergency].

Authors:  Francisco J Carod-Artal
Journal:  Rev Neurol       Date:  2015-03-16       Impact factor: 0.870

9.  Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.

Authors:  Jan E Carette; Matthijs Raaben; Anthony C Wong; Andrew S Herbert; Gregor Obernosterer; Nirupama Mulherkar; Ana I Kuehne; Philip J Kranzusch; April M Griffin; Gordon Ruthel; Paola Dal Cin; John M Dye; Sean P Whelan; Kartik Chandran; Thijn R Brummelkamp
Journal:  Nature       Date:  2011-08-24       Impact factor: 49.962

10.  Post-Ebola Syndrome, Sierra Leone.

Authors:  Janet T Scott; Foday R Sesay; Thomas A Massaquoi; Baimba R Idriss; Foday Sahr; Malcolm G Semple
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

View more
  13 in total

Review 1.  The ins and outs of virus trafficking through acidic Ca2+ stores.

Authors:  Gihan S Gunaratne; Jonathan S Marchant
Journal:  Cell Calcium       Date:  2022-01-06       Impact factor: 6.817

2.  Ebola Virus Entry Inhibitors.

Authors:  Ruikun Du; Qinghua Cui; Michael Caffrey; Lijun Rong
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  "Flash & Click": Multifunctionalized Lipid Derivatives as Tools To Study Viral Infections.

Authors:  Carsten Schultz; Scotland E Farley; Fikadu G Tafesse
Journal:  J Am Chem Soc       Date:  2022-07-28       Impact factor: 16.383

Review 4.  Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components.

Authors:  Dan Li; Xianzheng Wang; Yingzhao Liao; Shouchuan Wang; Jinjun Shan; Jianjian Ji
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

5.  N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus Infection.

Authors:  Nadishka Jayawardena; Linde A Miles; Laura N Burga; Charles Rudin; Matthias Wolf; John T Poirier; Mihnea Bostina
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

6.  TMEM41B and VMP1 are scramblases and regulate the distribution of cholesterol and phosphatidylserine.

Authors:  Yang Emma Li; Yichang Wang; Ximing Du; Tizhong Zhang; Hoi Yin Mak; Sarah E Hancock; Holly McEwen; Elvis Pandzic; Renee M Whan; Yvette Celine Aw; Ivan E Lukmantara; Yiqiong Yuan; Xiuju Dong; Anthony Don; Nigel Turner; Shiqian Qi; Hongyuan Yang
Journal:  J Cell Biol       Date:  2021-06-07       Impact factor: 10.539

7.  New insights into the role of endosomal proteins for African swine fever virus infection.

Authors:  Miguel Ángel Cuesta-Geijo; Isabel García-Dorival; Ana Del Puerto; Jesús Urquiza; Inmaculada Galindo; Lucía Barrado-Gil; Fátima Lasala; Ana Cayuela; Carlos Oscar S Sorzano; Carmen Gil; Rafael Delgado; Covadonga Alonso
Journal:  PLoS Pathog       Date:  2022-01-26       Impact factor: 6.823

Review 8.  Lassa virus glycoprotein complex review: insights into its unique fusion machinery.

Authors:  Hallie N Pennington; Jinwoo Lee
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840

Review 9.  Surfactants - Compounds for inactivation of SARS-CoV-2 and other enveloped viruses.

Authors:  Miriam Simon; Michael Veit; Klaus Osterrieder; Michael Gradzielski
Journal:  Curr Opin Colloid Interface Sci       Date:  2021-06-12       Impact factor: 6.448

10.  Aspects of Biological Replication and Evolution Independent of the Central Dogma: Insights from Protein-Free Vesicular Transformations and Protein-Mediated Membrane Remodeling.

Authors:  Aditya Mittal; Akanksha Chauhan
Journal:  J Membr Biol       Date:  2022-03-25       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.